Harrisvaccines Inc. Research Team Takes Advantage of Destron Fearing Bio-Thermo LifeChip(R) Technology
SO. ST. PAUL, Minn., Feb 22, 2010 (BUSINESS WIRE) -- Digital Angel /quotes/comstock/15*!diga/quotes/nls/diga (DIGA 0.47, 0.00, 0.00%) , an advanced technology company in the field of animal identification and emergency identification solutions, announced today that its Destron Fearing unit has been chosen to provide its Bio-Thermo(R) LifeChips(R) and DTR-4(R) hand-held readers to researchers to aid in the development of vaccines designed to protect swine from two of the industry's most costly diseases, Swine Influenza Virus (SIV) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
Thanks to a series of grants provided though the Iowa State Board of Regents, the University researchers are working on vaccines in conjunction with Hank Harris, Professor of Animal Science, and his company, Harrisvaccines Inc. (d/b/a Sirrah Bios) at the Iowa State University Research Park. Harrisvaccines Inc. is developing next-generation vaccines that utilize a common platform-based approach to livestock diseases.
Chief Technical Officer for influenza vaccine development at Harrisvaccines Inc., Ryan Vander Veen, added, "In our research studies with pigs, we have been inserting the LifeChips subcutaneously near the base of the ear in order to monitor temperature and look for a febrile response following a disease challenge. We have not noticed any problems with migration of the chips nor have we had any problems with collecting the readings. The LifeChip is a great product, and it has really made temperature collection easier; and I believe that it provides a much more accurate temperature reading without the stress of those collected by rectal thermometer."
Joseph J. Grillo, Chief Executive Officer of Digital Angel, said, "While most of our sales of the new Bio-Thermo LifeChip to date have been into the equine and companion pet markets, we are proud to be a part of this important and innovative effort to protect the swine population from two of its most costly diseases."
About Destron Fearing and Digital Angel
Destron Fearing is a subsidiary of Digital Angel /quotes/comstock/15*!diga/quotes/nls/diga (DIGA 0.47, 0.00, 0.00%) , an advanced technology company in the field of animal identification and emergency identification solutions. Digital Angel's products are utilized around the world in such applications as pet identification, using its patented, FDA-approved implantable microchip; livestock identification and herd management using visual and radio frequency identification (RFID) ear tags; and global positioning systems (GPS) search and rescue beacons for army, navy and air force applications worldwide. For further information please visit www.destronfearing.com and www.digitalangel.com.
This press release contains certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Forward-looking statements included in this press release include, without limitation, those concerning expectations regarding the expected benefits of the technology and impact of the awards on the Company's financial results. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Additional information about these and other factors that could affect the Company's businesses is set forth in the Company's Form 10-K under the caption "Risk Factors" filed with the Securities and Exchange Commission ("SEC") on March 31, 2009, and subsequent filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
SOURCE: Digital Angel
Jay McKeage, 651-554-1564